Africa Corporate Wellness Market, by End User, 2018-2027
Global Companion Diagnostics market [2016-2027] Asia Pacific by Technology
By Technology, the market is segmented into Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In Situ Hybridization (ISH), Immunohistochemistry (IHC), and Technology_Others (2016-2027)
| Label | Polymerase Chain Reaction (PCR) | Next-Generation Sequencing (NGS) | In Situ Hybridization (ISH) | Immunohistochemistry (IHC) | Technology_Others |
|---|---|---|---|---|---|
| 2016 | 242.09 USD Mn | 165.41 USD Mn | 122.52 USD Mn | 68.19 USD Mn | 46.65 USD Mn |
| 2017 | 262.77 USD Mn | 186.66 USD Mn | 136.91 USD Mn | 75.48 USD Mn | 51.62 USD Mn |
| 2018 | 285.01 USD Mn | 210.64 USD Mn | 152.98 USD Mn | 83.56 USD Mn | 57.12 USD Mn |
| 2019 | 328.47 USD Mn | 252.75 USD Mn | 181.77 USD Mn | 98.34 USD Mn | 67.21 USD Mn |
| 2020 | 199.08 USD Mn | 159.62 USD Mn | 113.67 USD Mn | 60.92 USD Mn | 41.62 USD Mn |
| 2021 | 270.88 USD Mn | 217.97 USD Mn | 147.61 USD Mn | 77.48 USD Mn | 55.73 USD Mn |
| 2022 | 354.93 USD Mn | 287.15 USD Mn | 184.93 USD Mn | 95.07 USD Mn | 72.00 USD Mn |
| 2023 | 439.13 USD Mn | 357.79 USD Mn | 219.13 USD Mn | 110.33 USD Mn | 87.97 USD Mn |
| 2024 | 522.37 USD Mn | 429.32 USD Mn | 250.05 USD Mn | 123.30 USD Mn | 103.51 USD Mn |
| 2025 | 620.46 USD Mn | 515.15 USD Mn | 285.33 USD Mn | 137.79 USD Mn | 121.79 USD Mn |
| 2026 | 735.93 USD Mn | 618.13 USD Mn | 325.58 USD Mn | 153.99 USD Mn | 143.30 USD Mn |
| 2027 | 871.71 USD Mn | 741.71 USD Mn | 371.52 USD Mn | 172.10 USD Mn | 168.61 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027] Asia Pacific by Technology portion of the Global Companion Diagnostics market [2016 market is on a steady long-term growth path. Segment value stands at roughly USD 1977 Mn in 2026 and is projected to reach USD 2326 Mn by 2027 — a gain of about 18% over the forecast period, translating to a CAGR in the double digits.
- polymerase chain reaction pcr segment accounted for the largest market share in 2019, this market is expected to reach USD 871. 71 Million in 2027 from USD 328.
- What the regional split looks like (2026): Polymerase Chain Reaction (PCR) leads, holding roughly 37% of segment value — the single largest regional share. Next-Generation Sequencing (NGS) is the second-largest contributor. In Situ Hybridization (ISH), Immunohistochemistry (IHC) and Technology_Others make up the remainder, in descending order.
- By 2027, Polymerase Chain Reaction (PCR) alone is expected to reach USD 872 Mn, with Next-Generation Sequencing (NGS) at USD 742 Mn.
Market Dynamics
polymerase chain reaction pcr segment accounted for the largest market share in 2019, this market is expected to reach USD 871.71 Million in 2027 from USD 328.47 Million in 2019. This market is projected to grow at a CAGR of 23.49% during the forecast period from 2020 - 2027. However, next generation sequencing ngs segment is the fastest growing market, which is expected to grow at a CAGR of 24.54% during the forecast period 2020 - 2027.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



